ERTA YOSHDAGI BOLALARGA UZOQ QO’LLANILGAN DORI PREPARATLARI TAʼSIRIDA YUZAGA KELGAN BUYRAKDAGI MORFOLOGIK O’ZGARISHLAR TAHLILI
Keywords:
buyrak to’qimasi, kiritmalar. go’daklar, koptokchalar, kanalchalar, mezangial xujayralar..Abstract
Go’daklar organizmi bu tibbiy jihatdan olganda tez moslashuvchanligi shu bilan birga tez beriluvchanligi va jarayonni salbiy tomonlarini yaqqol ko’rsatib berishga ulgurolmasdan qaytmas o’zgarishlarga olib keluvchi mavjudot sifatida ham qaralishi kerak…Yangi tugilgan vaqtdan toki 1 yoshgacha bo’lgan organizmda hali barcha anatomik, fiziologik, bioximik, gistologik shakllanish to’lik yakunlanmaganligi hattoki baʼzi organ tizimi batamom o’z funktsiyasini yo’lga ko’ymaganligi bois ekzogen kiritilgan kiritmalar organizmni qarshiligiga zarar keltirishi mumkin..Аynan aʼzolar orasida buyrak tuzilishi murakkabligi ,to’la to’kis shakllanmaganligi va uning gistologik strukturasida baʼzi xujayralarining yo’qligi uning qaytmas o’zgarishlar rivojlanishiga sharoit yaratadi…
References
West G.D. Childhood membranoproliferative glomerulonefritis: An approach to management.// Kidney Int.-1986..-Vol. 29 № 8.-P. 1077-1093.
Schmit H., Bohle A. Tubulointerstitial alternations in type I membranoproliferative glomerulonephritis. An investigation of 259 cases.// Path. Res. Pract. 1987.-Vol.182, №1-P.6-10.
Peruzzi L., et al. Tubulointerstitial responses in the рrogression of glomerular disseases: albuminuria modulates alpha-beta 5 integrin. Kidney Int. 1996 Oct; 50(4)1310-20.
Mactier R., et al. The natural History of embranous nephropathy in the west skotland.// Quart J. Med., New Sep.-1981.-Vol.60, № 232.-P.946-956.
Honkanen E. et al. Membranous glomerulonephritis in rheumatoid arthritis not related to goldor d-penicilamine therapy: a report of four cases and review of the literature.//Clin. Nephrol. -1986.-Vol.18. № 2.-P. 87-93.
Zucchelli P., Cagnoli L., Pasquali S et al. Clinical and morphologic evolution idiopathic membranous efropathy.// Clin Nephrol.- 1986.- Vol. 25.
Beck LH, Bonegio RG, Lambeau G. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361(1):11, 2009. doi: 10.1056/NEJMoa0810457
Fervenza FC, Appel GB, BarbourSJ, et al: Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med 381(1):36-46, 2019. doi: 10.1056/NEJMoa1814427
Ronco P, Debiec H. Molecular pathogenesis of membranous nephropathy. Annu Rev Pathol Mech Dis. 2020. 15:287–313 2.
Alsharhan L, Beck LH. Membranous Nephropathy: Core Curriculum 2021. Am J Kidne Dis. 2020; XX(XX):1-14. doi:10.1053/j.ajkd.2020.10.009 3.
Xu Z, Chen L, Xiang H et al. Advances in Pathogenesis of Idiopathic Membranous Nephropathy. Kidney Dis. 2020 Sep 6(5): 330-345. doi: 10.1159/00050770





